BACKGROUND: Previous data from our laboratory suggest that gonadally intact C57BL/6 male mice are more likely than their female counterparts to die from Plasmodium chabaudi infection, to recover more slowly from weight loss and hematocrit loss, and to have reduced interferon-gamma (IFN-gamma) and interleukin-10 (IL-10) responses. Removal of the ovaries, and hence, the primary production of sex steroids in females, reverses these differences. OBJECTIVE: We hypothesized that sex differences in response to P chabaudi may be mediated by differential synthesis of IFN-gamma and IL-10 that is influenced by estrogen, progesterone, or both. METHODS: C57BL/6 female mice (n = 200; n = 10/time point/treatment/experiment) were ovariectomized and implanted with a 21-day controlled-release pellet containing either 0.1 mg of 17beta-estradiol (E(2)), 10 mg of progesterone (P(4)), 0.1 mg of E(2) plus 10 mg of P(4), or cholesterol (placebo). Females were inoculated with 10(6)P chabaudi-infected erythrocytes. Body mass, body temperature, hematocrit, parasitemia, cytokine production, and antibody responses were monitored 0, 3, 5, 7, 10, 14, and 21 days postinoculation. RESULTS: Administration of E(2), either alone or in combination with P(4), mitigated infection-induced weight loss, hematocrit loss, and hypothermia, compared with females receiving placebo pellets (P < 0.05 in each case). Hormone treatment did not affect levels of parasitemia. Females administered E(2) alone or in combination with P(4) produced 4 to 7 times higher IFN-gamma and IL-10 during peak parasitemia than did females implanted with pellets containing either P(4) alone or placebo (P < 0.05 in each case). Exposure to E(2), either alone or in combination with P(4), increased anti-P chabaudi immunoglobulin G (IgG1) responses and the ratio of IgG1 to IgG2c (P < 0.05 in each case). CONCLUSION: This animal study suggests that physiological levels of estrogen, rather than progesterone, enhance immunity and, possibly, protect females from disease symptoms during malaria infection.
BACKGROUND: Previous data from our laboratory suggest that gonadally intact C57BL/6 male mice are more likely than their female counterparts to die from Plasmodium chabaudiinfection, to recover more slowly from weight loss and hematocrit loss, and to have reduced interferon-gamma (IFN-gamma) and interleukin-10 (IL-10) responses. Removal of the ovaries, and hence, the primary production of sex steroids in females, reverses these differences. OBJECTIVE: We hypothesized that sex differences in response to P chabaudi may be mediated by differential synthesis of IFN-gamma and IL-10 that is influenced by estrogen, progesterone, or both. METHODS: C57BL/6 female mice (n = 200; n = 10/time point/treatment/experiment) were ovariectomized and implanted with a 21-day controlled-release pellet containing either 0.1 mg of 17beta-estradiol (E(2)), 10 mg of progesterone (P(4)), 0.1 mg of E(2) plus 10 mg of P(4), or cholesterol (placebo). Females were inoculated with 10(6)P chabaudi-infected erythrocytes. Body mass, body temperature, hematocrit, parasitemia, cytokine production, and antibody responses were monitored 0, 3, 5, 7, 10, 14, and 21 days postinoculation. RESULTS: Administration of E(2), either alone or in combination with P(4), mitigated infection-induced weight loss, hematocrit loss, and hypothermia, compared with females receiving placebo pellets (P < 0.05 in each case). Hormone treatment did not affect levels of parasitemia. Females administered E(2) alone or in combination with P(4) produced 4 to 7 times higher IFN-gamma and IL-10 during peak parasitemia than did females implanted with pellets containing either P(4) alone or placebo (P < 0.05 in each case). Exposure to E(2), either alone or in combination with P(4), increased anti-P chabaudi immunoglobulin G (IgG1) responses and the ratio of IgG1 to IgG2c (P < 0.05 in each case). CONCLUSION: This animal study suggests that physiological levels of estrogen, rather than progesterone, enhance immunity and, possibly, protect females from disease symptoms during malaria infection.
Authors: Jürgen Krücken; Mohamed A Dkhil; Juliane V Braun; Regina M U Schroetel; Manal El-Khadragy; Peter Carmeliet; Horst Mossmann; Frank Wunderlich Journal: Infect Immun Date: 2005-01 Impact factor: 3.441
Authors: Ebru Karpuzoglu; Jillian B Fenaux; Rebecca A Phillips; Andrea J Lengi; François Elvinger; S Ansar Ahmed Journal: Endocrinology Date: 2005-11-17 Impact factor: 4.736
Authors: Rosana M F Libonati; Maristela G Cunha; José M Souza; Marcos V N Santos; Salma G Oliveira; Claudio T Daniel-Ribeiro; Leonardo J M Carvalho; José L M do Nascimento Journal: Neuroimmunomodulation Date: 2006-05-12 Impact factor: 2.492
Authors: Amy Cernetich; Lindsey S Garver; Anne E Jedlicka; Pamela W Klein; Nirbhay Kumar; Alan L Scott; Sabra L Klein Journal: Infect Immun Date: 2006-06 Impact factor: 3.441
Authors: Cherie L Butts; Shetha A Shukair; Kristina M Duncan; Eve Bowers; Cash Horn; Elena Belyavskaya; Leonardo Tonelli; Esther M Sternberg Journal: Int Immunol Date: 2007-02-07 Impact factor: 4.823
Authors: Flora Engelmann; Alex Barron; Henryk Urbanski; Martha Neuringer; Steven G Kohama; Byung Park; Ilhem Messaoudi Journal: Age (Dordr) Date: 2010-09-03
Authors: Ebru Karpuzoglu; Chad W Schmiedt; Julian Pardo; Megan Hansen; Tai L Guo; Steven D Holladay; Robert M Gogal Journal: Endocrinology Date: 2014-05-19 Impact factor: 4.736
Authors: Melanie Bannister-Tyrrell; Nguyen Xuan Xa; Johanna Helena Kattenberg; Nguyen Van Van; Vu Khac Anh Dung; Truong Minh Hieu; Nguyen Van Hong; Eduard Rovira-Vallbona; Nguyen Thanh Thao; Tran Thanh Duong; Anna Rosanas-Urgell; Koen Peeters Grietens; Annette Erhart Journal: Malar J Date: 2018-03-19 Impact factor: 2.979